RESMED, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 210.2 USD | -0.70% |
|
-0.47% | +22.18% |
| Jun. 11 | Resmed Insider Sold Shares Worth $3,107,739, According to a Recent SEC Filing | MT |
| May. 23 | ResMed Says Research Shows Effectiveness of Positive Airway Pressure Therapy For Sleep Apnea | MT |
ETFs positioned on ResMed, Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 114 M€ | +4.13% | - | |
| 3.07% | 132 M€ | +9.49% | - |
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows:
- medical devices (50.4%);
- masks (37.9%);
- software as a service (11.7%).
At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia.
The United States accounts for 61.4% of net sales.
Calendar
2024-07-31
- Q4 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
210.2
USD
Average target price
218.7
USD
Spread / Average Target
+4.06%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +22.18% | 30.87B | |
| +8.50% | 220B | |
| +12.93% | 194B | |
| +24.13% | 149B | |
| +33.45% | 113B | |
| +4.52% | 65.75B | |
| +14.10% | 52.43B | |
| +4.08% | 50.47B | |
| -4.98% | 38.54B | |
| -3.34% | 34.12B |
- Stock Market
- Equities
- RMD Stock
- Funds and ETFs ResMed, Inc.
